Sapiens International (SPNS) has had the highest return between October 7, 2025 and January 7, 2026 by a mid-cap US stock, returning 32,304.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Sapiens International (SPNS) | 10/7/2025 - 1/7/2026 | 32,304.18% |
Praxis Precision Medicines (PRAX) | 10/7/2025 - 1/7/2026 | 425.21% |
Terns Pharmaceuticals (TERN) | 10/7/2025 - 1/7/2026 | 356.19% |
Hycroft Mining (HYMC) | 10/7/2025 - 1/7/2026 | 346.41% |
PACS (PACS) | 10/7/2025 - 1/7/2026 | 194.31% |
Vicor (VICR) | 10/7/2025 - 1/7/2026 | 175.36% |
Cidara Therapeutics (CDTX) | 10/7/2025 - 1/7/2026 | 126.92% |
Olema Pharmaceuticals (OLMA) | 10/7/2025 - 1/7/2026 | 126.4% |
Nuvation Bio (NUVB) | 10/7/2025 - 1/7/2026 | 125.8% |
Celcuity LLC (CELC) | 10/7/2025 - 1/7/2026 | 118.7% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 10/7/2025 - 1/7/2026 | 117.69% |
Cogent Biosciences (COGT) | 10/7/2025 - 1/7/2026 | 117.65% |
Central Puerto (CEPU) | 10/7/2025 - 1/7/2026 | 111.08% |
BBVA Banco Frances SA ADR (BBAR) | 10/7/2025 - 1/7/2026 | 110.26% |
Wave Life Sciences (WVE) | 10/7/2025 - 1/7/2026 | 107.82% |
Banco Macro SA B ADR (BMA) | 10/7/2025 - 1/7/2026 | 107.79% |
Belite Bio Inc ADR (BLTE) | 10/7/2025 - 1/7/2026 | 103.4% |
Victoria's Secret (VSCO) | 10/7/2025 - 1/7/2026 | 101.9% |
Apogee Therapeutics, Inc Common Stock (APGE) | 10/7/2025 - 1/7/2026 | 96.46% |
Arrowhead Pharmaceuticals (ARWR) | 10/7/2025 - 1/7/2026 | 88.42% |
Grupo Financiero Galicia SA ADR (GGAL) | 10/7/2025 - 1/7/2026 | 88.11% |
Spyre Therapeutics (SYRE) | 10/7/2025 - 1/7/2026 | 81.83% |
American Eagle Outfitters (AEO) | 10/7/2025 - 1/7/2026 | 79.11% |
Establishment Labs (ESTA) | 10/7/2025 - 1/7/2026 | 74.39% |
Amicus Therapeutics (FOLD) | 10/7/2025 - 1/7/2026 | 71.84% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
